<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">38904142</PMID><DateCompleted><Year>2024</Year><Month>06</Month><Day>21</Day></DateCompleted><DateRevised><Year>2024</Year><Month>07</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2044-6055</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>6</Issue><PubDate><Year>2024</Year><Month>Jun</Month><Day>19</Day></PubDate></JournalIssue><Title>BMJ open</Title><ISOAbbreviation>BMJ Open</ISOAbbreviation></Journal><ArticleTitle>Cohort profile: the Johns Hopkins COVID Long Study (JHCLS)-a US nationwide prospective cohort study.</ArticleTitle><Pagination><StartPage>e077742</StartPage><MedlinePgn>e077742</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e077742</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/bmjopen-2023-077742</ELocationID><Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">COVID-19 continues to affect millions of individuals worldwide, both in the short and long term. The post-acute complications of SARS-CoV-2 infection, referred to as long COVID, result in diverse symptoms affecting multiple organ systems. Little is known regarding how the symptoms associated with long COVID progress and resolve over time. The Johns Hopkins COVID Long Study aims to prospectively examine the short-term and long-term consequences of COVID-19 in individuals both with and without a history of SARS-CoV-2 infection using self-reported data collected in an online survey.</AbstractText><AbstractText Label="PARTICIPANTS" NlmCategory="METHODS">16 764 adults with a history of SARS-CoV-2 infection and 799 adults without a history of SARS-CoV-2 infection who completed an online baseline survey.</AbstractText><AbstractText Label="FINDINGS TO DATE" NlmCategory="RESULTS">This cohort profile describes the baseline characteristics of the Johns Hopkins COVID Long Study. Among 16 764 participants with a history of SARS-CoV-2 infection and defined long COVID status, 75% reported a very good or excellent health status prior to infection, 99% reported experiencing at least one COVID-19 symptom during the acute phase of infection, 9.9% reported hospitalisation and 63% were defined as having long COVID using the WHO definition.</AbstractText><AbstractText Label="FUTURE PLANS" NlmCategory="UNASSIGNED">Analysis of longitudinal data will be used to investigate the progression and resolution of long COVID symptoms over time.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wentz</LastName><ForeName>Eryka</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-9056-0436</Identifier><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA ewentz1@jhu.edu.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ni</LastName><ForeName>Zhanmo</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Oncology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yenokyan</LastName><ForeName>Karine</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vergara</LastName><ForeName>Candelaria</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pahwa</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Oral Health Sciences, Temple University Maurice H. Kornberg School of Dentistry, Philadelphia, Pennsylvania, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kammerling</LastName><ForeName>Thea</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xiao</LastName><ForeName>Pu</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Data Science, Johns Hopkins University Whiting School of Engineering, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duggal</LastName><ForeName>Priya</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lau</LastName><ForeName>Bryan</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mehta</LastName><ForeName>Shruti H</ForeName><Initials>SH</Initials><AffiliationInfo><Affiliation>Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, Maryland, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>P30 AI094189</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>06</Month><Day>19</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMJ Open</MedlineTA><NlmUniqueID>101552874</NlmUniqueID><ISSNLinking>2044-6055</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="UpdateOf"><RefSource>medRxiv. 2024 Apr 26:2024.04.25.24306387. doi: 10.1101/2024.04.25.24306387</RefSource><PMID Version="1">38712261</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="Y">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006760" MajorTopicYN="N">Hospitalization</DescriptorName><QualifierName UI="Q000706" MajorTopicYN="N">statistics &amp; numerical data</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057566" MajorTopicYN="N">Self Report</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006304" MajorTopicYN="N">Health Status</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Chronic Disease</Keyword><Keyword MajorTopicYN="N">EPIDEMIOLOGIC STUDIES</Keyword><Keyword MajorTopicYN="N">INFECTIOUS DISEASES</Keyword></KeywordList><CoiStatement>Competing interests: SHM receives material support from Abbott Laboratories (not related to this study).</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>6</Month><Day>21</Day><Hour>5</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>6</Month><Day>19</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38904142</ArticleId><ArticleId IdType="pmc">PMC11191784</ArticleId><ArticleId IdType="doi">10.1136/bmjopen-2023-077742</ArticleId><ArticleId IdType="pii">bmjopen-2023-077742</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bourmistrova NW, Solomon T, Braude P, et al. . Long-term effects of COVID-19 on mental health: A systematic review. J Affect Disord 2022;299:118&#x2013;25:S0165-0327(21)01253-2. 10.1016/j.jad.2021.11.031</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jad.2021.11.031</ArticleId><ArticleId IdType="pmc">PMC8758130</ArticleId><ArticleId IdType="pubmed">34798148</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, et al. . Post-acute COVID-19 syndrome. Nat Med 2021;27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Raman B, Bluemke DA, L&#xfc;scher TF, et al. . Long COVID: post-acute sequelae of COVID-19 with a cardiovascular focus. Eur Heart J 2022;43:1157&#x2013;72. 10.1093/eurheartj/ehac031</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/eurheartj/ehac031</ArticleId><ArticleId IdType="pmc">PMC8903393</ArticleId><ArticleId IdType="pubmed">35176758</ArticleId></ArticleIdList></Reference><Reference><Citation>Montani D, Savale L, Noel N, et al. . Post-acute COVID-19 syndrome. Eur Respir Rev 2022;31:210185. 10.1183/16000617.0185-2021</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/16000617.0185-2021</ArticleId><ArticleId IdType="pmc">PMC8924706</ArticleId><ArticleId IdType="pubmed">35264409</ArticleId></ArticleIdList></Reference><Reference><Citation>Soriano JB, Murthy S, Marshall JC, et al. . A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 2022;22:e102&#x2013;7:S1473-3099(21)00703-9. 10.1016/S1473-3099(21)00703-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(21)00703-9</ArticleId><ArticleId IdType="pmc">PMC8691845</ArticleId><ArticleId IdType="pubmed">34951953</ArticleId></ArticleIdList></Reference><Reference><Citation>Perlis RH, Santillana M, Ognyanova K, et al. . Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open 2022;5:e2238804. 10.1001/jamanetworkopen.2022.38804</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.38804</ArticleId><ArticleId IdType="pmc">PMC9614581</ArticleId><ArticleId IdType="pubmed">36301542</ArticleId></ArticleIdList></Reference><Reference><Citation>van Kessel SAM, Olde Hartman TC, Lucassen PLBJ, et al. . Post-acute and long-COVID-19 symptoms in patients with mild diseases: a systematic review. Fam Pract 2022;39:159&#x2013;67. 10.1093/fampra/cmab076</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/fampra/cmab076</ArticleId><ArticleId IdType="pmc">PMC8414057</ArticleId><ArticleId IdType="pubmed">34268556</ArticleId></ArticleIdList></Reference><Reference><Citation>Domingo FR, Waddell LA, Cheung AM, et al. . Prevalence of long-term effects in individuals diagnosed with COVID-19: an updated living systematic review. Epidemiology [Preprint] 2021. 10.1101/2021.06.03.21258317</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/2021.06.03.21258317</ArticleId></ArticleIdList></Reference><Reference><Citation>Castanares-Zapatero D, Chalon P, Kohn L, et al. . Pathophysiology and mechanism of long COVID: a comprehensive review. Ann Med 2022;54:1473&#x2013;87. 10.1080/07853890.2022.2076901</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/07853890.2022.2076901</ArticleId><ArticleId IdType="pmc">PMC9132392</ArticleId><ArticleId IdType="pubmed">35594336</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Sanchez I, Rodriguez-Ma&#xf1;as L, Laosa O. Long COVID-19: the need for an Interdisciplinary approach. Clin Geriatr Med 2022;38:533&#x2013;44:S0749-0690(22)00005-2. 10.1016/j.cger.2022.03.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cger.2022.03.005</ArticleId><ArticleId IdType="pmc">PMC8934714</ArticleId><ArticleId IdType="pubmed">35868671</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J, Jansari V, Hornig M, et al. . Unexplained post-acute infection syndromes. Nat Med 2022;28:911&#x2013;23. 10.1038/s41591-022-01810-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramakrishnan RK, Kashour T, Hamid Q, et al. . Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol 2021;12:686029. 10.3389/fimmu.2021.686029</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.686029</ArticleId><ArticleId IdType="pmc">PMC8278217</ArticleId><ArticleId IdType="pubmed">34276671</ArticleId></ArticleIdList></Reference><Reference><Citation>Pavli A, Theodoridou M, Maltezou HC. Post-COVID syndrome: incidence, clinical spectrum, and challenges for primary Healthcare professionals. Arch Med Res 2021;52:575&#x2013;81:S0188-4409(21)00081-3. 10.1016/j.arcmed.2021.03.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arcmed.2021.03.010</ArticleId><ArticleId IdType="pmc">PMC8093949</ArticleId><ArticleId IdType="pubmed">33962805</ArticleId></ArticleIdList></Reference><Reference><Citation>Karuna S, Gallardo-Cartagena JA, Theodore D, et al. . Post-COVID symptom profiles and duration in a global Convalescent COVID-19 observational cohort: correlations with demographics, medical history, acute COVID-19 severity and global region. J Glob Health 2023;13:06020. 10.7189/jogh.13.06020</Citation><ArticleIdList><ArticleId IdType="doi">10.7189/jogh.13.06020</ArticleId><ArticleId IdType="pmc">PMC10289480</ArticleId><ArticleId IdType="pubmed">37352144</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Thielke R, et al. . Research electronic data capture (Redcap)&#x2014;A Metadata-driven methodology and Workflow process for providing Translational research Informatics support. J Biomed Inform 2009;42:377&#x2013;81. 10.1016/j.jbi.2008.08.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2008.08.010</ArticleId><ArticleId IdType="pmc">PMC2700030</ArticleId><ArticleId IdType="pubmed">18929686</ArticleId></ArticleIdList></Reference><Reference><Citation>Harris PA, Taylor R, Minor BL, et al. . The Redcap consortium: building an international community of software platform partners. J Biomed Inform 2019;95:103208:S1532-0464(19)30126-1. 10.1016/j.jbi.2019.103208</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbi.2019.103208</ArticleId><ArticleId IdType="pmc">PMC7254481</ArticleId><ArticleId IdType="pubmed">31078660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrucci L. The Baltimore longitudinal study of aging (BLSA): a 50-year-long journey and plans for the future. J Gerontol A Biol Sci Med Sci 2008;63:1416&#x2013;9. 10.1093/gerona/63.12.1416</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/gerona/63.12.1416</ArticleId><ArticleId IdType="pmc">PMC5004590</ArticleId><ArticleId IdType="pubmed">19126858</ArticleId></ArticleIdList></Reference><Reference><Citation>Stone JL, Norris AH. Activities and attitudes of participants in the Baltimore longitudinal study. J Gerontol 1966;21:575&#x2013;80. 10.1093/geronj/21.4.575</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/geronj/21.4.575</ArticleId><ArticleId IdType="pubmed">5918312</ArticleId></ArticleIdList></Reference><Reference><Citation>Godin G. The Godin-&#xad;Shephard Leisure-&#xad;Time physical activity questionnaire. Health Fit J Can 2011;4:18&#x2013;22. 10.14288/hfjc.v4i1.82</Citation><ArticleIdList><ArticleId IdType="doi">10.14288/hfjc.v4i1.82</ArticleId></ArticleIdList></Reference><Reference><Citation>Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci 1985;10:141&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">4053261</ArticleId></ArticleIdList></Reference><Reference><Citation>Amireault S, Godin G. The Godin-Shephard leisure-time physical activity questionnaire: validity evidence supporting its use for classifying healthy adults into active and insufficiently active categories. Percept Mot Skills 2015;120:604&#x2013;22. 10.2466/03.27.PMS.120v19x7</Citation><ArticleIdList><ArticleId IdType="doi">10.2466/03.27.PMS.120v19x7</ArticleId><ArticleId IdType="pubmed">25799030</ArticleId></ArticleIdList></Reference><Reference><Citation>Vlahov D, Anthony JC, Munoz A, et al. . The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: description of methods and characteristics of participants. NIDA Res Monogr 1991;109:75&#x2013;100.</Citation><ArticleIdList><ArticleId IdType="pubmed">1661376</ArticleId></ArticleIdList></Reference><Reference><Citation>Rassu AL, Evangelista E, Barateau L, et al. . Idiopathic Hypersomnia severity scale to better quantify symptoms severity and their consequences in idiopathic Hypersomnia. J Clin Sleep Med 2022;18:617&#x2013;29. 10.5664/jcsm.9682</Citation><ArticleIdList><ArticleId IdType="doi">10.5664/jcsm.9682</ArticleId><ArticleId IdType="pmc">PMC8805002</ArticleId><ArticleId IdType="pubmed">34596041</ArticleId></ArticleIdList></Reference><Reference><Citation>Dauvilliers Y, Evangelista E, Barateau L, et al. . Measurement of symptoms in idiopathic Hypersomnia: the idiopathic Hypersomnia severity scale. Neurology 2019;92:e1754&#x2013;62. 10.1212/WNL.0000000000007264</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000007264</ArticleId><ArticleId IdType="pubmed">30867266</ArticleId></ArticleIdList></Reference><Reference><Citation>Bentall RP, Wood GC, Marrinan T, et al. . A brief mental fatigue questionnaire. Br J Clin Psychol 1993;32:375&#x2013;9. 10.1111/j.2044-8260.1993.tb01070.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.2044-8260.1993.tb01070.x</ArticleId><ArticleId IdType="pubmed">7902751</ArticleId></ArticleIdList></Reference><Reference><Citation>Spitzer RL, Kroenke K, Williams JBW, et al. . A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 2006;166:1092&#x2013;7. 10.1001/archinte.166.10.1092</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinte.166.10.1092</ArticleId><ArticleId IdType="pubmed">16717171</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudolph JE, Zhong Y, Duggal P, et al. . Defining representativeness of study samples in medical and population health research. BMJ Med 2023;2:e000399. 10.1136/bmjmed-2022-000399</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjmed-2022-000399</ArticleId><ArticleId IdType="pmc">PMC10193086</ArticleId><ArticleId IdType="pubmed">37215072</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>